AstraZeneca PLC (LSE:AZN) - Share price


Stock Report

AstraZeneca PLC AZN

Activity Analysis
 Turnover ($)Pre-tax ($)
 2018201920182019
Total22,09023,56500
Single Segment22,090000
Tagrisso03,18900
Symbicort02,49500
Brilinta01,58100
Farxiga01,54300
Nexium01,48300
Imfinzi01,46900
Pulmicort01,46600
Crestor01,27800
Lynparza01,19800
Faslodex089200
Zoladex081300
Seloken/Toprol-XL076000
Fasenra070400
Bydureon054900
Onglyza052700
Iressa042300
Respiratory Others039000
Synagis035800
Others030600
CVRM Others027100
Losec/Prilosec026300
Arimidex022500
Atacand022100
Daliresp/Daxas021500
Casodex020000
Seroquel XR/IR019100
Calquence016400
Byetta011000
Oncology Others09400
Duaklir07700
Other diabetes05200
Bevespi04200
Lokelma01400
Breztri0200
Geographical Analysis
 Turnover ($)Pre-tax ($)
 2018201920182019
Total22,09023,5651,9930
US7,2407,74700
China3,7784,89900
Europe04,35000
Established Rest of World03,30300
Emerging Markets03,26600
United Kingdom2,3900-5140
Japan1,952000
Others - Continental Europe1,312000
Others - Asia, Africa and Australasia1,308000
Others - Americas806000
France617000
Germany592000
Canada483000
Sweden477000
Italy426000
Spain396000
Australia313000
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.